lornoxicam

09/01/2010 - "Preoperative lornoxicam administration resulted in a significant reduction in pain scores postoperatively in the infiltration and i.v. groups with no significant difference between them. "
01/01/2008 - "Analgesic efficacy of quick-release versus standard lornoxicam for pain after third molar surgery: a randomized, double-blind, placebo-controlled, single-dose trial."
01/01/2015 - "Lornoxicam, a relatively new NSAID, is effective in relieving pain accompanying different oro-dental problems. "
04/20/1991 - "The pain experienced after third molar surgery was used as a model to evaluate the analgesic efficacy of a new non-steroidal anti-inflammatory drug, lornoxicam, in a Phase II study. "
01/01/2014 - "Perioperative dexketoprofen or lornoxicam administration for pain management after major orthopedic surgery: a randomized, controlled study."

01/01/2014 - "Preemptive lornoxicam is effective for postoperative pain control."
09/01/2009 - "Lornoxicam is a new nonsteroidal anti-inflammatory drug (NSAID) that has been shown to be effective and well tolerated in the treatment of postoperative pain. "
01/01/2014 - "The purpose of this study was to evaluate the postoperative pain relief and opioid-sparing effects of dexketoprofen and lornoxicam after major orthopedic surgery. "
08/01/2013 - "There are a growing number of clinical studies documenting lornoxicam effects for short-term treatment of acute postoperative pain following various surgical procedures. "
01/01/2010 - "This study aimed to evaluate the safety of analgesic regimens including the NSAID lornoxicam in the short-term treatment of postoperative pain in a clinically relevant population. "

08/01/2002 - "[Long term study on the efficacy and safety of lornoxicam in rheumatoid arthritis]."
01/01/2015 - "Our main aim was to target lornoxicam to treat rheumatoid arthritis as per the chronotherapeutic pattern of the disease. "
01/01/2013 - "Thus, formulated dual cross-linked beads when administered at bed time may release lornoxicam when needed most for chronotherapeutics of early morning rheumatoid arthritis attacks in chronic patients. "
08/01/2002 - "Lornoxicam presented a worth-while therapeutic action and a good tolerability in rheumatoid arthritis long term treatment."
08/01/2002 - "To assess the long term safety and therapeutic action of lornoxicam, a new non steroidal anti-inflammatory agent, in rheumatoid arthritis. "

09/01/2002 - "Additional effects of using local anesthetic wound infiltration to the use of lornoxicam could not be demonstrated."
01/01/2015 - "After the thyroidectomy was performed, patients in group I underwent wound infiltration with 4 mg of lornoxicam and patients in group II received the same amount of saline. "
01/01/2015 - "Wound infiltration with lornoxicam neither improved postoperative pain control nor decreased total analgesic consumption."
01/01/2015 - "Efficacy of wound infiltration with lornoxicam for postoperative analgesia following thyroidectomy: a prospective, randomized, double-blind study."
01/01/2008 - "We assessed the analgesic efficacy of lornoxicam when administered as an adjuvant to levobupivacaine wound infiltration after varicocoele operation. "

01/01/1990 - "Three studies reported here have confirmed that lornoxicam is effective in osteoarthritis and the ideal dose appears to be 12 mg daily. "
02/01/1992 - "A multicentre, randomised, double blind, parallel group study was undertaken to compare the efficacy and tolerance of four weeks' treatment with lornoxicam (6 mg once daily, 4 mg twice daily, and 6 mg twice daily) and placebo in patients with osteoarthritis of the hip or knee. "
02/01/1992 - "A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee."
01/01/2011 - "A comprehensive profile on lornoxicam, the oxicam nonsteroidal anti-inflammatory agent which is used in the muscular skeletal and joint disorders such as osteoarthritis and rheumatoid arthritis, is prepared. "
01/01/2004 - "Lornoxicam and rofecoxib are effective in the treatment of patients with activated osteoarthritis; the analgesic and anti-inflammatory effects of lornoxicam are significantly superior to those of rofecoxib without inferiority in tolerability."